Evidence map›Paper›PMID 34187490›Full record

ReviewThrombosis journal2021

A review of thromboembolic events in hospitalized COVID-19 patients.

Paul Fontelo, Mrigendra M Bastola, Zhaonian Zheng, Seo Hyon Baik

Registry-linked trialAbstract readReview
In one paragraph

Review in Thrombosis journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04998799 (Current Practices on Antithrombotic Therapy in Hospitalised and Discharged Patients With COVID-19), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04998799 completednot on this map

Current Practices on Antithrombotic Therapy in Hospitalised and Discharged Patients With COVID-19

TypeobservationalSponsorNMC Specialty HospitalRan2021 to 2021Enrolled435ConditionsCOVID-19 Pneumonia, Thrombosis, COVID-19 Acute Respiratory Distress Syndrome, Severe Acute Respiratory Syndrome (SARS) PneumoniaArmsCurrent clinical practices of participating physicians
3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Neuropsychiatric disorders and COVID-19.The lancet. Psychiatry · 2021
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Paul FonteloApplied Clinical Informatics Branch, Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD, 20894, USA. pfontelo@nih.gov.ORCID http://orcid.org/0000-0003-3186-3215
Mrigendra M BastolaApplied Clinical Informatics Branch, Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD, 20894, USA.
Zhaonian ZhengApplied Clinical Informatics Branch, Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD, 20894, USA.
Seo Hyon BaikApplied Clinical Informatics Branch, Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD, 20894, USA.

Funding

Applied Clinical InformaticsZIHLM010016 · NLM · NATIONAL LIBRARY OF MEDICINE · PI LYNCH, PAUL · 2021 to 2025
$36.5M
Clinical and Informatics Research on Large Clinical DatabasesZIALM010008 · NLM · NATIONAL LIBRARY OF MEDICINE · PI MCDONALD, CLEMENT · 2016 to 2025
$9.3M
6 · The paper itself

Abstract

contextA higher incidence of thromboembolic disorders in COVID-19 has been reported by many clinicians worldwide. OBJECTIVE, DESIGN AND DATA SOURCES: Selected studies found in PubMed that reported thromboembolic events were included for meta-analysis using weighted fixed and random effects. Data from 19 articles on cohort studies in patients diagnosed with COVID-19 and thromboembolic events, including thrombosis and embolism were included in this review.

resultsThe likelihood for developing thromboembolic disorders in hospitalized COVID-19 patients was 0.28 (95% CI 0.21-0.36).

conclusionThis study further validates the increased risk of VTE in COVID-19 patients when compared to healthy, non-hospitalized people, and hospitalized patients. These findings will be useful to researchers and medical practitioners caring for COVID-19 patients.

Identifiers

PMID34187490
PMCPMC8240420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.